NuVasive (NUVA +5.6%) gets a pop from an upgrade to Outperform at RBC Capital. The firm says...

|By:, SA News Editor

NuVasive (NUVA +5.6%) gets a pop from an upgrade to Outperform at RBC Capital. The firm says that the results of a recent survey of U.S. spine surgeons show the Street may be underestimating the near-term sustainability of the medical device company's U.S. lumbar revenue growth rate.